This was described as a strategic funding round. The company said the new investment brings total funding to over 50 million USD.
About Epoch Biodesign
A London-based startup developing enzymatic recycling technology that breaks down nylon 6.6 waste into its original chemical building blocks to produce virgin-quality recycled nylon using programmable biology, AI, and synthetic biology.
London, United Kingdom
Read Company ProfileFrequently Asked Questions
What type of funding round did Epoch Biodesign raise?
Epoch Biodesign raised a unspecified round.
How much did Epoch Biodesign raise in its unspecified?
Epoch Biodesign raised $12,000,000 USD in its unspecified.
Who invested in Epoch Biodesign's unspecified?
The investors in Epoch Biodesign's unspecified are: lululemon, KOMPAS VC, Happiness Capital, Extantia, Leitmotif.
What type of investment was Epoch Biodesign's unspecified?
Epoch Biodesign's unspecified was a equity investment.
How will Epoch Biodesign use the funds from its unspecified?
Epoch Biodesign plans to use the funds for: commercialisation of recycled nylon 6,6, scale production from a pilot facility to a larger demonstration site, validate commercial-scale output, expand global commercialisation efforts, deepen partnerships across apparel and automotive industries.